U.S. markets closed
  • S&P 500

    4,070.56
    +10.13 (+0.25%)
     
  • Dow 30

    33,978.08
    +28.67 (+0.08%)
     
  • Nasdaq

    11,621.71
    +109.30 (+0.95%)
     
  • Russell 2000

    1,911.46
    +8.39 (+0.44%)
     
  • Crude Oil

    79.38
    -1.63 (-2.01%)
     
  • Gold

    1,943.90
    -2.80 (-0.14%)
     
  • Silver

    23.73
    -0.30 (-1.23%)
     
  • EUR/USD

    1.0874
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    3.5180
    +0.0250 (+0.72%)
     
  • GBP/USD

    1.2395
    -0.0012 (-0.10%)
     
  • USD/JPY

    129.8000
    -0.3530 (-0.27%)
     
  • BTC-USD

    23,215.22
    +170.38 (+0.74%)
     
  • CMC Crypto 200

    526.66
    +9.65 (+1.87%)
     
  • FTSE 100

    7,765.15
    +4.04 (+0.05%)
     
  • Nikkei 225

    27,382.56
    +19.81 (+0.07%)
     

Colgate-Palmolive: Q4 Earnings Insights

 

Shares of Colgate-Palmolive (NYSE:CL) decreased 0.6% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share were up 5.48% year over year to $0.77, which beat the estimate of $0.76.

Revenue of $4,324,000,000 rose by 7.70% year over year, which beat the estimate of $4,140,000,000.

Guidance

Colgate said it sees FY21 net sales growth of 4%-7% year over year.

How To Listen To The Conference Call

Date: Jan 29, 2021

View more earnings on CL

Time: 08:30 AM

ET Webcast URL: https://investor.colgatepalmolive.com/events-and-presentations

Price Action

Company's 52-week high was at $86.41

Company's 52-week low was at $58.49

Price action over last quarter: down 1.92%

Company Profile

Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries around the world (international sales account for about 70% of its consolidated total, including approximately 50% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.